Home > Drug Search >
  • company_query: Afexa Life Sciences
  •   > 
Drug Filter
Category:
chemistry (22) biology (5)
Status:
Phase Ⅲ (3) Phase Ⅱ (11) Phase Ⅰ (13)
Clinical Stage:
Pending (7) Active (16) Discontinued (4)
Bio-Type:
Vaccine (3) Recombinant enzyme (1)
Indication:
Squamous cell cancer (1) Actinic keratosis (AK) (1) Acute lymphoblastic leukaemia (ALL) (1) Basal cell carcinoma (BCC) (1) Breast cancer (1) Chronic lymphocytic leukemia (CLL) (1) Cystic fibrosis (CF) (1) Follicular lymphoma (1) Heart failure (1) Hypercholesterolemia (1) Ischaemia (1) Lymphoma (2) Malignancies (1) Multiple sclerosis (MS) (1) Non small cell lung cancer (NSCLC) (1) Osteoarthritis (OA) (1) Ovarian cancer (1) Pancreatic cancer (2) Postoperative pain (1) Renal cell carcinoma (1) Rheumatoid arthritis (RA) (2) Small cell lung cancer (SCLC) (1) Solid tumours (3) Head and neck cancer (1) Malignant glioma (1) Malaria (1) Contraception (1) Eosinophilic esophagitis (EoE) (1) Portal hypertension (1) Acute radiation syndrome (1) Astrocytoma (1) Graft versus host disease (1) Chronic myelomonocytic leukemia(CMML) (1) Celiac disease (1) hematological malignancies (2) Ebola virus disease (EVD) (1) Cardiovascular disorders (1) Inflammatory pain (1)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 2 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top